Los Angeles Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Los Angeles Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,663	Closed	-$54K	–	1419
2022 Q2	$54K	Sell	32,663 -167,162	-84%	-$347K	﹤0.01%	1299
2022 Q1	$587K	Buy	199,825 +101,895	+104%	+$357K	﹤0.01%	973
2021 Q4	$468K	Hold	97,930	–	–	﹤0.01%	1042
2021 Q3	$741K	Buy	+97,930	New	+$627K	﹤0.01%	878

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Los Angeles Capital Management's SURF Position: Q3 2022 in Review

Los Angeles Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 32,663 shares — an estimated $54K sold.

Los Angeles Capital Management first reported a position in SURF in Q3 2021 and held it in 4 quarters. The position peaked at $741K in Q3 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

Los Angeles Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Los Angeles Capital Management sold 32,663 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $54K.
Los Angeles Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Los Angeles Capital Management's Surface Oncology, Inc. Common Stock position peaked at $741K in Q3 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.